Q32 Bio is a publicly traded corporation whose shares are listed and actively traded on the Nasdaq Global Market under the ticker symbol QTTB. By operating as a public entity, the company gains access to broader public capital markets, allowing it to execute underwritten common stock offerings, private placements, and warrant issuances to secure the substantial liquidity required for ongoing clinical research programs.